Insiders · Profile

Ye Weiguo

Chief Operating Officer at GYRE THERAPEUTICS. Filing since 14 May 2026. CIK 0001985496

Company

Date

Role

Action

Shares

Amount

Of holding

GYRE GYRE THERAPEUTICS, INC.

18 Jun 2026

Chief Operating Officer

Sold at will

3,000

$19.05K

0.4%

GYRE GYRE THERAPEUTICS, INC.

11 Jun 2026

Chief Operating Officer

Sold at will

2,800

$17.28K

0.4%

GYRE GYRE THERAPEUTICS, INC.

10 Jun 2026

Chief Operating Officer

Sold at will

11,418

$71.06K

1.6%

GYRE GYRE THERAPEUTICS, INC.

9 Jun 2026

Chief Operating Officer

Sold at will

17,500

$107.48K

2.4%

GYRE GYRE THERAPEUTICS, INC.

5 Jun 2026

Chief Operating Officer

Sold at will

15,401

$98.57K

2.2%

GYRE GYRE THERAPEUTICS, INC.

4 Jun 2026

Chief Operating Officer

Sold at will

19,575

$119.99K

2.7%

GYRE GYRE THERAPEUTICS, INC.

26 May 2026

Chief Operating Officer

Sold at will

4,000

$24.40K

0.6%

GYRE GYRE THERAPEUTICS, INC.

22 May 2026

Chief Operating Officer

Sold at will

3,500

$21.28K

0.5%

GYRE GYRE THERAPEUTICS, INC.

21 May 2026

Chief Operating Officer

Sold at will

12,820

$78.84K

1.8%

GYRE GYRE THERAPEUTICS, INC.

20 May 2026

Chief Operating Officer

Sold at will

9,400

$57.81K

1.3%

GYRE GYRE THERAPEUTICS, INC.

19 May 2026

Chief Operating Officer

Sold at will

9,120

$58.09K

1.3%

GYRE GYRE THERAPEUTICS, INC.

18 May 2026

Chief Operating Officer

Sold at will

200

$1.32K

0.0%

GYRE GYRE THERAPEUTICS, INC.

15 May 2026

Chief Operating Officer

Sold at will

13,100

$87.12K

1.8%

GYRE GYRE THERAPEUTICS, INC.

14 May 2026

Chief Operating Officer

Sold at will

15,580

$107.66K

2.2%

14 decisions on file.